Se asocia con falla temprana del injerto | 04 MAY 15

Cirugía de bypass infrainguinal y consumo de tabaco

El propósito de este estudio fue evaluar el impacto de fumar activamente en el preoperatorio, sobre la ocurrencia de falla del injerto dentro de los 30 días después de la cirugía de bypass infrainguinal.
Autor/a: Dres. Selvarajah S, Black JH III, Malas MB, Lum YW, Propper BW, Abularrage CJ J Vasc Surg 2014; 59(5): 1308-14
INDICE:  1.  | 2. Referencias

1.    C.W. Cole, G.B. Hill, E. Farzad, A. Bouchard, D. Moher, K. Rody et al. Cigarette smoking and peripheral arterial occlusive disease. Surgery, 114 (1993), pp. 753–756
2.    H. Drexel, J. Steurer, J. Muntwyler, S. Meienberg, H.R. Schmid, E. Schneider et al. Predictors of the presence and extent of peripheral arterial occlusive disease. Circulation, 94 (Suppl) (1996), pp. II199–II205
3.    M.D. Muller, A.B. Reed, U.A. Leuenberger, L.I. Sinoway. Physiology in medicine: peripheral arterial disease. J Appl Physiol, 115 (2013), pp. 1219–1226
4.    W.B. Kannel, D. Shurtleff. The Framingham study. Cigarettes and the development of intermittent claudication. Geriatrics, 28 (1973), pp. 61–68
5.    N.W. Shammas. Epidemiology, classification, and modifiable risk factors of peripheral arterial disease. Vasc Health Risk Manag, 3 (2007), pp. 229–234
6.    Centers for Disease Control and Prevention. Current cigarette smoking among adults—United States, 2011. MMWR, 61 (2012), pp. 889–894
7.    Y. Ostchega, R. Paulose-Ram, C.F. Dillon, Q. Gu, J.P. Hughes. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the national health and nutrition examination survey 1999-2004. J Am Geriatr Soc, 55 (2007), pp. 583–589
8.    E. Selvin, T.P. Erlinger. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the national health and nutrition examination survey, 1999-2000. Circulation, 110 (2004), pp. 738–743
9.    A.W. Hoel, B.W. Nolan, P.P. Goodney, Y. Zhao, A. Schanzer, A.C. Stanley et al. Variation in smoking cessation after vascular operations. J Vasc Surg, 57 (2013), pp. 1338–1344
10.    A. Schanzer, N. Hevelone, C.D. Owens, M. Belkin, D.F. Bandyk, A.W. Clowes et al. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg, 46 (2007), pp. 1180–1190
11.    A. Gardner. The effect of cigarette smoking on exercise capacity in patients with intermittent claudication. Vasc Med, 1 (1996), pp. 181–186
12.    D. Hennrikus, A.M. Joseph, H.A. Lando, S. Duval, L. Ukestad, M. Kodl et al. Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol, 56 (2010), pp. 2105–2112
13.    Department of Health and Human Services. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease. A report of the Surgeon-General 2010. Available at: Accessed July 2, 2013.
14.    F. Akinbami, R. Askari, J. Steinberg, M. Panizales, S.O. Rogers Jr. Factors affecting morbidity in emergency general surgery. Am J Surg, 201 (2011), pp. 456–462
15.    R.O. Wein. Preoperative smoking cessation: impact on perioperative and long-term complications. Arch Otolaryngol Head Neck Surg, 135 (2009), pp. 597–601
16.    J.A. Singh, T.K. Houston, B.A. Ponce, G. Maddox, M.J. Bishop, J. Richman et al. Smoking as a risk factor for short-term outcomes following primary total hip and total knee replacement in veterans. Arthritis Care Res (Hoboken), 63 (2011), pp. 1365–1374
17.    A. Saxena, L. Shan, D.T. Dinh, J.A. Smith, G.C. Shardey, C.M. Reid et al. Impact of smoking status on early and late outcomes after isolated aortic valve replacement surgery. J Heart Valve Dis, 22 (2013), pp. 184–191
18.    D. Khullar. The impact of smoking on surgical outcomes. J Am Coll Surg, 215 (2012), pp. 418–426
19.    E.M. Willigendael, J.A.W. Teijink, M. Bartelink, R.J.G. Peters, H.R. Büller, M.H. Prins. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg, 42 (2005), pp. 67–74
20.    A.J. Meltzer, G. Evangelisti, A.R. Graham, P.H. Connolly, D.W. Jones, H.L. Bush et al. Determinants of outcome after endovascular therapy for critical limb ischemia with tissue loss. Ann Vasc Surg, 28 (2014), pp. 144–151
21.    R.T. Lancaster, M.F. Conrad, V.I. Patel, R.P. Cambria, G.M. LaMuraglia. Predictors of early graft failure after infrainguinal bypass surgery: a risk-adjusted analysis from the NSQIP. Eur J Vasc Endovasc Surg, 43 (2012), pp. 549–555
22.    N. Singh, A.N. Sidawy, K.J. DeZee, R.F. Neville, C. Akbari, W. Henderson. Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg, 47 (2008), pp. 556–561
23.    W.G. Henderson, J. Daley. Design and statistical methodology of the national surgical quality improvement program: why is it what it is? Am J Surg, 198 (Suppl) (2009), pp. S19–S27
24.    M. Shiloach, S.K. Frencher Jr., J.E. Steeger, K.S. Rowell, K. Bartzokis, M.G. Tomeh et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J Am Coll Surg, 210 (2010), pp. 6–16
25.    T. Jonason, R. Bergström. Cessation of smoking in patients with intermittent claudication. effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand, 221 (1987), pp. 253–260
26.    L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, F.G. Fowkes et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg, 45 (Suppl S) (2007), pp. S5–S67
27.    M.S. Conte. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes. J Vasc Surg, 52 (Suppl) (2010), pp. 96S–103S
28.    A. Carter, M.O. Murphy, A.T. Halka, N.J. Turner, J.P. Kirton, D. Murray et al. The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program. Ann Vasc Surg, 21 (2007), pp. 695–703
29.    C.L. Grines, E.J. Topol, W.W. O'Neill, B.S. George, D. Kerelakes, H.R. Phillips et al. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation, 91 (1995), pp. 298–303
30.    V.G. Nielsen, D.T. Hafner, E.B. Steinbrenner. Tobacco smoke-induced hypercoagulation in human plasma: role of carbon monoxide. Blood Coagul Fibrinolysis, 24 (2013), pp. 405–410
31.    W.E. Stites, J.W. Froude 2nd. Does the oxidation of methionine in thrombomodulin contribute to the hypercoagulable state of smokers and diabetics?. Med Hypotheses, 68 (2007), pp. 811–821
32.    J.M. Samet. The 1990 Report of the Surgeon General: the health benefits of smoking cessation. Am Rev Respir Dis, 142 (1990), pp. 993–994
33.    G.A. Merrell, R.J. Gusberg. Infrainguinal bypass conduit: autogenous or synthetic—a national perspective. Vasc Endovascular Surg, 36 (2002), pp. 247–254
34.    E. Arvela, M. Söderström, A. Albäck, P. Aho, M. Venermo, M. Lepäntalo. Arm vein conduit vs prosthetic graft in infrainguinal revascularization for critical leg ischemia. J Vasc Surg, 52 (2010), pp. 616–623
35.    W.P. Robinson, C.D. Owens, L.L. Nguyen, T.T. Chong, M.S. Conte, M. Belkin. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage. J Vasc Surg, 49 (2009), pp. 1416–1425
36.    K.H. Holman, P.K. Henke, J.B. Dimick, J.D. Birkmeyer. Racial disparities in the use of revascularization before leg amputation in Medicare patients. J Vasc Surg, 54 (2011), pp. 420–426



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2022